ACR 2022 Tweet by sheila

In this prospective cohort study by Dr Jacquez, there was a statistically significant inverse assoc bet. average yearly HCQ dose and overall damage accrual 👇

Reassuring data.
☝️HCQ consistently proves to be a beneficial drug for #lupus
#ACR22 @Rheumnow ABST#0982 @rheumarhyme